Early neurological symptoms and epilepsy outcomes in individuals with the recurrent <scp> <i>GABRG2</i> </scp> p.( <scp>Ala106Thr</scp> ) gain‐of‐function variant: Structural and phenotypic insights

Although some individuals exhibited severe developmental impairment without epilepsy, our findings demonstrate that the recurrent GABRG2 p.(Ala106Thr) GoF variant is consistently associated with a severe neurodevelopmental phenotype. Despite its profound clinical impact, in silico tools consistently predict this variant as benign, highlighting a critical gap in current predictive models.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2025-12-06
DOI
https://doi.org/10.1111/epi.70045
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.( Ala106Thr ) gain‐of‐function variant: Structural and phenotypic insights

Guido Rubboli, Susan X. N. Lin, Viviana Rizzo, Francesca Bisulli et al.
Epilepsia
Genomics and Rare Diseases
article

Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.( Ala106Thr ) gain‐of‐function variant: Structural and phenotypic insights

Guido Rubboli, Susan X. N. Lin, Viviana Rizzo, Francesca Bisulli, Megan Yabumoto, Elena Gardella, Tommy Stödberg, Reetta Kälviäinen, Ali S. Kusay, Sebastian Ortiz, Lino Nobili, Leena Jutila, Tommaso Lo Barco, Elisabetta Cesaroni, Philip K. Ahring, Katri Silvennoinen, Sara I. Liin, Federico Torta, Rikke S. Møller, Anni Saarela, Laura Licchetta, Rebekka S. Dahl, Carla Marini, Ghayda Mirzaa, Elisa Fallica, Felipe Castro‐Villablanca, Alessandra Rossi, Chiara Bagliani, Christian Laugaard‐Jacobsen
article en

Abstract

Although some individuals exhibited severe developmental impairment without epilepsy, our findings demonstrate that the recurrent GABRG2 p.(Ala106Thr) GoF variant is consistently associated with a severe neurodevelopmental phenotype. Despite its profound clinical impact, in silico tools consistently predict this variant as benign, highlighting a critical gap in current predictive models.

EpilepsiaVol. 67(3)
Linköping University (SE), Universidad de Santiago de Chile (CL), University of Verona (IT), University of Copenhagen (DK), Seattle Children's Hospital (US), The University of Sydney (AU), Karolinska University Hospital (SE), University of Eastern Finland (FI), University of Southern Denmark (DK), University of Ferrara (IT), University of Washington (US), Alexander von Humboldt Biological Resources Research Institute (CO), Aalborg University Hospital (DK), Istituto Giannina Gaslini (IT), Karolinska Institutet (SE), UNSW Sydney (AU), Clínica Las Condes (CL), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Norcliffe Foundation (US), Kuopio University Hospital (FI), Istituto delle Scienze Neurologiche di Bologna (IT), Ospedale San Bassiano (IT), Epilepsy Action (GB), Epilepsy Foundation (AU), Ospedali Riuniti Umberto I (IT), Azienda Ospedaliera Carlo Poma (IT), University of Chile (CL), University of Genoa (IT), Aalborg University (DK), University of Bologna (IT)
Openalex Percentile: Top 60%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.